These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19293087)

  • 21. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Furin J; Diacon AH; Andries K
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):4-5. PubMed ID: 28157457
    [No Abstract]   [Full Text] [Related]  

  • 22. Household screening and multidrug-resistant tuberculosis.
    Cox H; van Cutsem G
    Lancet; 2011 Jan; 377(9760):103-4. PubMed ID: 21145582
    [No Abstract]   [Full Text] [Related]  

  • 23. Outbreak of multidrug-resistant tuberculosis on Daru Island: an update.
    Kase P; Dakulala P; Bieb S
    Lancet Respir Med; 2016 Aug; 4(8):e40. PubMed ID: 27342263
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidemiological and cost analysis of multidrug-resistant tuberculosis in Oman.
    Mohammadi A; Nassor ZS; Behlim T; Mohammadi E; Govindarajan R; Al Maniri A; Smego RA
    East Mediterr Health J; 2008; 14(6):1240-5. PubMed ID: 19161099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing MDR tuberculosis in Nepal.
    Cousins S
    Lancet; 2018 May; 391(10132):1760-1761. PubMed ID: 29739554
    [No Abstract]   [Full Text] [Related]  

  • 27. European guidance on drug-resistant tuberculosis in children and adolescents.
    Gröschel MI; Seddon JA; Prabowo SA; Migliori GB; Graham SM; van den Boom M; Dara M
    Lancet Child Adolesc Health; 2020 Jan; 4(1):9-11. PubMed ID: 31676193
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of drug-resistant TB with individualised DST--the way forward?
    Singhal T; Gupta N
    J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
    [No Abstract]   [Full Text] [Related]  

  • 29. Changing the game for multidrug-resistant tuberculosis.
    Ghanashyam B
    Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324
    [No Abstract]   [Full Text] [Related]  

  • 30. Tuberculosis in correctional facilities : a nightmare without end in sight.
    Laniado-Laborín R
    Chest; 2001 Mar; 119(3):681-3. PubMed ID: 11243941
    [No Abstract]   [Full Text] [Related]  

  • 31. Current updates in tuberculosis.
    Mishra G
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):1. PubMed ID: 28077854
    [No Abstract]   [Full Text] [Related]  

  • 32. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 33. New tuberculosis tests and drugs remain out of reach.
    Makoni M
    Lancet Infect Dis; 2021 Feb; 21(2):174. PubMed ID: 33515522
    [No Abstract]   [Full Text] [Related]  

  • 34. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
    Lobato MN; Jereb JA; Castro KG
    Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tuberculosis--still increasing threat. Time for mobilization over the national borders].
    Larsson LO
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-resistant tuberculosis: World Health Organization launches global response plan 2007-2008.
    Euro Surveill; 2007 Jul; 12(7):E070705.3. PubMed ID: 17868565
    [No Abstract]   [Full Text] [Related]  

  • 37. New diagnostics, available care offer hope to patients with drug-resistant tuberculosis.
    Sibbald B
    CMAJ; 2013 Jan; 185(1):E21-2. PubMed ID: 23228998
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis: prevention is better than cure.
    Gilbert GL
    Med J Aust; 1996 Jan; 164(2):121-4. PubMed ID: 8569564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 40. The global threat of drug-resistant tuberculosis.
    Snider DE; Castro KG
    N Engl J Med; 1998 Jun; 338(23):1689-90. PubMed ID: 9614262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.